Strategies to combat Tay-Sachs disease - ScienceDirect
Por um escritor misterioso
Descrição
Spontaneous appearance of Tay–Sachs disease in an animal model - ScienceDirect
PDF) Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease
Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment - Genetics in Medicine
Introduction of an N-Glycan Sequon Into HEXA Enhances Human β-Hexosaminidase Cellular Uptake in a Model of Sandhoff Disease: Molecular Therapy
Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity: Molecular Therapy
PDF) An Inducible Mouse Model of Late Onset Tay–Sachs Disease
PDF) Generation of HEXA-deficient hiPSCs from fibroblasts of a Tay-Sachs disease patient
HEXA and Tay-Sachs Disease - ppt download
Beta N Acetylhexosaminidase A - an overview
Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity: Molecular Therapy
Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier - ScienceDirect
Natural history of Tay-Sachs disease in sheep - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
